These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 5487063
1. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia. Li LH, Olin EJ, Buskirk HH, Reineke LM. Cancer Res; 1970 Nov; 30(11):2760-9. PubMed ID: 5487063 [No Abstract] [Full Text] [Related]
2. Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole. Brockman RW, Shaddix S, Laster WR, Schabel FM. Cancer Res; 1970 Sep; 30(9):2358-68. PubMed ID: 5475481 [No Abstract] [Full Text] [Related]
3. Action of camptothecin on mammalian cells in culture. Li LH, Fraser TJ, Olin EJ, Bhuyan BK. Cancer Res; 1972 Dec; 32(12):2643-50. PubMed ID: 4674679 [No Abstract] [Full Text] [Related]
4. Phase specificity of 5-azacytidine against mammalian cells in tissue culture. Li LH, Olin EJ, Fraser TJ, Bhuyan BK. Cancer Res; 1970 Nov; 30(11):2770-5. PubMed ID: 5487064 [No Abstract] [Full Text] [Related]
5. Effects of 4,4'-diacetyldiphenylurea-bis-(guanylhydrazone) on the incorporation of precursors into nucleic acid and protein of leukemia L1210. Soucek J, Ehrke MJ, Mihich E. Cancer Res; 1970 Aug; 30(8):2187-94. PubMed ID: 5459766 [No Abstract] [Full Text] [Related]
6. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075). Allen LM, Creaven PJ. Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799 [No Abstract] [Full Text] [Related]
7. Metabolic effects of cyclic 9- -D-arabinofuranosyladenine 3',5'-monophosphate in L1210 cells. Hughes RG, Kimball AP. Cancer Res; 1972 Sep; 32(9):1791-4. PubMed ID: 4345037 [No Abstract] [Full Text] [Related]
8. Biological and biochemical differences between tubercidin (7-deazaadenosine) and its 5'-phosphate methyl ester. Bhuyan BK, Neil GL, Smith CG, Olin EJ, Li LH. Cancer Res; 1971 Dec; 31(12):1923-9. PubMed ID: 5120290 [No Abstract] [Full Text] [Related]
9. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells. Wang JJ, Chervinsky DS, Rosen JM. Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305 [No Abstract] [Full Text] [Related]
10. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase. Hoshi A, Kanzawa F, Kuretani K, Kanai T, Ichino M. Biochem Pharmacol; 1973 Nov 15; 22(22):2829-34. PubMed ID: 4761553 [No Abstract] [Full Text] [Related]
11. Studies on the mode of action of the copper(II)chelate of 2-keto-3-ethoxybutyraldehyde-bis(thiosemicarbazone). Bhuyan BK, Betz T. Cancer Res; 1968 Apr 15; 28(4):758-63. PubMed ID: 5649064 [No Abstract] [Full Text] [Related]
12. Effect of neocarzinostatin on DNA synthesis in L1210 cells. Sawada H, Tatsumi K, Sasada M, Shirakawa S, Nakamura T. Cancer Res; 1974 Dec 15; 34(12):3341-6. PubMed ID: 4473265 [No Abstract] [Full Text] [Related]
13. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine). Bach MK. Cancer Res; 1969 May 15; 29(5):1036-44. PubMed ID: 5781095 [No Abstract] [Full Text] [Related]
14. Studies on a cell line derived from the L1210 murine leukemia with altered surface properties and decreased capacity for tumor production. Kessel D, Bosmann HB. Cancer Res; 1974 Mar 15; 34(3):603-8. PubMed ID: 4855835 [No Abstract] [Full Text] [Related]
15. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia. Li LH, Neil GL, Moxley TE, Olin EJ. Cancer Chemother Rep; 1974 Mar 15; 58(3):345-52. PubMed ID: 4858297 [No Abstract] [Full Text] [Related]
16. Specific metabolic changes in DNA-treated L1210 leukemia cells. Glick JL, Sahler C. Cancer Res; 1967 Dec 15; 27(12):2342-9. PubMed ID: 4230120 [No Abstract] [Full Text] [Related]
17. The action of streptozotocin on mammalian cells. Bhuyan BK. Cancer Res; 1970 Jul 15; 30(7):2017-23. PubMed ID: 5456086 [No Abstract] [Full Text] [Related]
18. On the characteristics of actinomycin D resistance in L5178Y cells. Kessel D, Bosmann HB. Cancer Res; 1970 Nov 15; 30(11):2695-701. PubMed ID: 4321087 [No Abstract] [Full Text] [Related]
19. Some determinants of camptothecin responsiveness in leukemia L1210 cells. Kessel D. Cancer Res; 1971 Dec 15; 31(12):1883-7. PubMed ID: 5120286 [No Abstract] [Full Text] [Related]
20. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts. Schrecker AW. Cancer Res; 1970 Mar 15; 30(3):632-41. PubMed ID: 5425288 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]